Review
Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow
Affiliations
- PMID: 2073686
Item in Clipboard
Review
Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow
Crit Rev Ther Drug Carrier Syst.
1990.
Abstract
The ability of the bone marrow to remove particulate matters from the circulation, opens up perhaps an opportunity for the delivery of therapeutic agents by means of colloidal drug carrier systems such as liposomes, emulsions, nanoparticles, etc. for the treatment of diseases and disorders of this multifunctional organ of the body. This article is designed to provide a critical review on fundamentals, problems, current progress, and future prospects of site-specific delivery of intravenously injected colloidal drug carriers to the bone marrow.
Similar articles
-
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection.Crit Rev Ther Drug Carrier Syst. 1994;11(1):31-59. Crit Rev Ther Drug Carrier Syst. 1994. PMID: 7704918 Review.
-
Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems.Int J Pharm. 2011 Sep 30;417(1-2):120-37. doi: 10.1016/j.ijpharm.2011.02.001. Epub 2011 Feb 16. Int J Pharm. 2011. PMID: 21310225 Review.
-
Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I.Drug Dev Ind Pharm. 2011 Feb;37(2):178-84. doi: 10.3109/03639045.2010.502534. Epub 2010 Aug 12. Drug Dev Ind Pharm. 2011. PMID: 21073322
-
Lipid vesicles and other colloids as drug carriers on the skin.Adv Drug Deliv Rev. 2004 Mar 27;56(5):675-711. doi: 10.1016/j.addr.2003.10.028. Adv Drug Deliv Rev. 2004. PMID: 15019752 Review.
-
Past and future evolution in colloidal drug delivery systems.Expert Opin Drug Deliv. 2008 Jan;5(1):69-85. doi: 10.1517/17425247.5.1.69. Expert Opin Drug Deliv. 2008. PMID: 18095929 Review.
Cited by
-
New technologies for drug delivery across the blood brain barrier.Curr Pharm Des. 2004;10(12):1355-63. doi: 10.2174/1381612043384826. Curr Pharm Des. 2004. PMID: 15134486 Free PMC article. Review.
-
Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles.Int J Nanomedicine. 2011;6:203-11. doi: 10.2147/IJN.S16165. Epub 2011 Jan 24. Int J Nanomedicine. 2011. PMID: 21445276 Free PMC article.
-
Particulate systems for targeting of macrophages: basic and therapeutic concepts.J Innate Immun. 2012;4(5-6):509-28. doi: 10.1159/000339153. Epub 2012 Jun 19. J Innate Immun. 2012. PMID: 22722900 Free PMC article. Review.
-
Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.Prog Polym Sci. 2007;32(8-9):1054-1082. doi: 10.1016/j.progpolymsci.2007.05.014. Prog Polym Sci. 2007. PMID: 20234846 Free PMC article.
-
PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1.Bioconjug Chem. 2008 Jan;19(1):145-52. doi: 10.1021/bc700227z. Epub 2007 Nov 13. Bioconjug Chem. 2008. PMID: 17997512 Free PMC article.